The viral vector and plasmid DNA manufacturing market generated USD 5.33 B in 2023 and is expected to reach USD 19.50 B by 2030 with a 20.3% CAGR, driven by rising gene therapy, vaccine, and cell therapy production. https://www.datamintelligence.com/research-report/viral-vector-and-plasmid-dna-manufacturing-market?dr